Plain-English translation of NCT07328607 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer, minimally invasive surgical technique can safely treat pancreatic and bile duct tumors as well as the traditional open surgery approach. In minimally invasive surgery, surgeons use small incisions and specialized instruments to remove the tumor, while traditional surgery involves one larger incision. The study will follow 90 patients randomly assigned to one of these two surgical methods to see which approach leads to better outcomes and fewer complications.
Minimally invasive surgery has become standard for many procedures because patients recover faster and have less pain, but it has not been widely adopted for complex pancreatic surgery. This trial aims to determine whether the new treatment can deliver the same cancer-fighting results as traditional surgery while offering patients the potential benefits of faster recovery.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to receive either the minimally invasive surgical approach (using small incisions) or the traditional open surgical approach. You will undergo the assigned surgery to remove your tumor, and your surgical team will carefully monitor you for 90 days after surgery to track your recovery, any complications, and how well your cancer was treated. During this time, you will have follow-up visits and assessments to compare how each surgical approach affects your healing and outcomes.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Egypt